Evidence map›Paper›PMID 39535720›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Defining the True Native Ends of RNAs at Single-Molecule Level with TERA-Seq.

Fadia Ibrahim, Zissimos Mourelatos

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Fadia IbrahimDepartment of Biochemistry and Molecular Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA. fadia.ibrahim@jefferson.edu.
Zissimos MourelatosDepartment of Pathology and Laboratory Medicine, Division of Neuropathology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Funding

X-Ray Crystallography and Macromolecular CharacterizationP30CA056036 · NCI · THOMAS JEFFERSON UNIVERSITY · PI Claudio Guillermo Giraudo · 1995 to 2026
$94.8M
Mechanism for post-transcriptional gene regulation by RibothrypsisR01GM149825 · NIGMS · THOMAS JEFFERSON UNIVERSITY · PI FADIA Fayez IBRAHIM · 2023 to 2026
$1.4M
Ribothrypsis: mechanisms and implications for gene expression regulationR01GM133154 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI MOURELATOS, ZISSIMOS · 2019 to 2022
$1.3M
NCI NIH HHS P30 CA056036NIGMS NIH HHS R01 GM133154NIGMS NIH HHS R01 GM149825
6 · The paper itself

Abstract

Turnover of messenger RNAs (mRNAs) is a highly regulated process and serves to control expression of RNA molecules and to eliminate aberrant transcripts. Profiling mRNA decay using short-read sequencing methods that target either the 5' or 3' ends of RNAs, overlooks valuable information about the other end, which could provide significant insights into biological aspects and mechanisms of RNA decay. Oxford Nanopore Technology (ONT) is rapidly emerging as a powerful platform for direct sequencing of native, single-RNA molecules. However, as currently designed, the existing ONT platform is unable to sequence the very 5' ends of RNAs and is limited to polyadenylated molecules. Here, we present a detailed step-by-step experimental protocol for True End-to-end RNA Sequencing (TERA-Seq), a new method that addresses ONT's limitations, allowing accurate representation and characterization of RNAs at the level of single molecules. TERA-Seq describes both poly- and non-polyadenylated RNA molecules and accurately identifies their native ends by ligating uniquely designed adapters to the 5' ends (5TERA), the 3' ends (TERA3), or both ends (5TERA3) that are sequenced along with the transcripts.

Indexed as

Sequence Analysis, RNAHigh-Throughput Nucleotide SequencingHumansRNARNA, MessengerRNA StabilityRNARNA, MessengerDirect RNA sequencingEnd-to-end sequencingMessenger RNAsNative RNA endsONTOxford Nanopore TechnologyRNA decaySingle-RNA molecule sequencingTERA-Seq

Identifiers

PMID39535720
PMCPMC12013618

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.